Literature DB >> 33675370

Phenanthrenoid Coelogin Isolated from Coelogyne cristata Exerts Osteoprotective Effect Through MAPK-Mitogen-Activated Protein Kinase Signaling Pathway.

Ravi Prakash1, Tripti Mishra2, Kapil Dev3, Kriti Sharma1, Jitendra Kuldeep4, Aijaz Ahmad John1, Alok Tripathi1, Chetan Sharma3, Kamal Ram Arya3, Brijesh Kumar5, Mohd Imran Siddiqi4, Narender Tadigoppula6, Divya Singh7.   

Abstract

Osteoporosis is a major health problem in postmenopausal women globally. This study determined the mechanism through which coelogin stimulates osteoblastogenesis and its osteoprotective and bone regenerating potential. Coelogin effect on primary calvarial osteoblast cells was determined by measuring alkaline phosphatase activity, mineralization, osteoblast survival, and apoptosis and protein expression studies. The osteoprotective effect of coelogin was also evaluated on osteopenic adult female Swiss mice. At autopsy, bones were collected for dynamic and histomorphometry studies. Serum samples were also collected for assessment of serum parameters. Coelogin treatment led to increased osteoblast proliferation, survival, differentiation, and mineralization in osteoblast cells. Coelogin supplementation to Ovx mice promoted new bone formation, prevented Ovx-induced deterioration of bone microarchitecture, and enhanced bone regeneration. In addition, signaling studies revealed that coelogin treatment activates the ER-Erk and Akt-dependent signaling pathways which stimulate the osteoblastogenesis in osteoblast cells.

Entities:  

Year:  2021        PMID: 33675370     DOI: 10.1007/s00223-021-00818-3

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  24 in total

1.  Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone.

Authors:  R L Jilka; R S Weinstein; T Bellido; P Roberson; A M Parfitt; S C Manolagas
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

Review 2.  Contribution of bone mineral density and bone turnover markers to the estimation of risk of osteoporotic fracture in postmenopausal women.

Authors:  P Garnero; P D Delmas
Journal:  J Musculoskelet Neuronal Interact       Date:  2004-03       Impact factor: 2.041

3.  Variants of self-assembling peptide, KLD-12 that show both rapid fracture healing and antimicrobial properties.

Authors:  Jitendra K Tripathi; Subhashis Pal; Bhanupriya Awasthi; Amit Kumar; Anshika Tandon; Kalyan Mitra; Naibedya Chattopadhyay; Jimut Kanti Ghosh
Journal:  Biomaterials       Date:  2015-04-16       Impact factor: 12.479

4.  Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells.

Authors:  H Dobnig; R T Turner
Journal:  Endocrinology       Date:  1995-08       Impact factor: 4.736

5.  Quality of Life in Hypoparathyroidism Improves With rhPTH(1-84) Throughout 8 Years of Therapy.

Authors:  Gaia Tabacco; Yu-Kwang Donovan Tay; Natalie E Cusano; John Williams; Beatriz Omeragic; Rukhana Majeed; Maximo Gomez Almonte; Mishaela R Rubin; John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2019-07-01       Impact factor: 5.958

6.  Theophylline, a methylxanthine drug induces osteopenia and alters calciotropic hormones, and prophylactic vitamin D treatment protects against these changes in rats.

Authors:  Subhashis Pal; Kainat Khan; Shyamsundar Pal China; Monika Mittal; Konica Porwal; Richa Shrivastava; Isha Taneja; Zakir Hossain; Dhanaraju Mandalapu; Jiaur R Gayen; Muhammad Wahajuddin; Vishnu Lal Sharma; Arun K Trivedi; Sabyasachi Sanyal; Smrati Bhadauria; Madan M Godbole; Sushil K Gupta; Naibedya Chattopadhyay
Journal:  Toxicol Appl Pharmacol       Date:  2016-02-03       Impact factor: 4.219

7.  Prevalence of Osteoporosis and Low Bone Mass Among Puerto Rican Older Adults.

Authors:  Sabrina E Noel; Kelsey M Mangano; John L Griffith; Nicole C Wright; Bess Dawson-Hughes; Katherine L Tucker
Journal:  J Bone Miner Res       Date:  2017-12-07       Impact factor: 6.741

8.  Ethanolic extract of Coelogyne cristata Lindley (Orchidaceae) and its compound coelogin promote osteoprotective activity in ovariectomized estrogen deficient mice.

Authors:  Chetan Sharma; Mohd Nizam Mansoori; Manisha Dixit; Priyanka Shukla; Tejaswita Kumari; S P S Bhandari; T Narender; Divya Singh; K R Arya
Journal:  Phytomedicine       Date:  2014-09-16       Impact factor: 5.340

9.  Methoxylated isoflavones, cajanin and isoformononetin, have non-estrogenic bone forming effect via differential mitogen activated protein kinase (MAPK) signaling.

Authors:  Biju Bhargavan; Abnish Kumar Gautam; Divya Singh; Amit Kumar; Sumit Chaurasia; Abdul Malik Tyagi; Dinesh Kumar Yadav; Jay Sharan Mishra; Amar Bahadur Singh; Sabyasachi Sanyal; Atul Goel; Rakesh Maurya; Naibedya Chattopadhyay
Journal:  J Cell Biochem       Date:  2009-10-01       Impact factor: 4.429

Review 10.  Potential new drug targets for osteoporosis.

Authors:  Chad Deal
Journal:  Nat Clin Pract Rheumatol       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.